2
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Conditions
Pain
27
Neoplasms
20
Cancer Pain
10
Colonic Neoplasms
7
Breakthrough Pain
7
Agnosia
7
Breast Neoplasms
5
Rectal Neoplasms
4
Prostatic Neoplasms
4
Lung Neoplasms
4
Head and Neck Neoplasms
4
Chronic Pain
4
Urinary Bladder Neoplasms
3
Sarcoma
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Pancreatic Neoplasms
3
Pain, Postoperative
3
Lymphoma, Follicular
3
Breakthrough Cancer Pain
3
Waldenstrom Macroglobulinemia
2
Uterine Cervical Neoplasms
2
Thrombocythemia, Essential
2
Sezary Syndrome
2
Primary Myelofibrosis
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Polycythemia Vera
2
Pleural Effusion, Malignant
2
Pdgfra-Associated Chronic Eosinophilic Leukemia
2
Myeloproliferative Disorders
2
Mycosis Fungoides
2
Interventions
Pregabalin
5
Lidocaine
4
Surveys and Questionnaires
3
Bupivacaine
3
ziconotide
2
Transcranial Magnetic Stimulation
2
Oxycodone
2
Gabapentin
2
Capsaicin
2
Amitriptyline
2
onabotulinum toxin A
1
nabiximols
1
Yoga
1
Vitamin B 6
1
Vitamin B 12
1
Vinorelbine
1
Vincristine
1
Transcutaneous Electric Nerve Stimulation
1
Thalidomide
1
Telmisartan
1
Tapentadol
1
Spinal Cord Stimulation
1
Sodium Chloride
1
Saline Solution
1
Radiofrequency Ablation
1
Plastic Surgery Procedures
1
Paclitaxel
1
Oxaliplatin
1
Morphine
1
Methadone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neuralgia
×
Fentanyl
×
Clear all
NCT01946555
2016-04-14
RER
Mario Negri Institute for Pharmacological Research
Completed
150 enrolled